NexTech AR Reports $6 million in Revenues for its Audited Period Ended December 31st 2019
NEW YORK and TORONTO, March 27, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
AgraFlora Organics’ GTA Facility Receives Amendments Necessary to Launch CBD Business
VANCOUVER, British Columbia, March 27, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) […]
CORRECTION: Green Thumb Industries (GTI) Announces Fourth Quarter Revenue of $75.8 Million and Fourth Quarter Adjusted Operating EBITDA of $14.4 Million
In the press release published at 4:00 p.m. EST on March 26, 2020, the Fourth Quarter and Full Year 2019 […]
Green Thumb Industries (GTI) Announces Fourth Quarter Revenue of $75.8 Million and Fourth Quarter Adjusted Operating EBITDA of $14.4 Million
Full year revenue of $216.4 millionDelivers on new store opening guidance for FY 2019Kicks off 2020 with successful launch of […]
RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution
TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: […]
Ayr Strategies Provides Latest Update in Response to COVID-19 Developments
TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr”), a vertically-integrated cannabis multi-state operator […]
XORTX Announces New Clinical Advisory Board Member
CALGARY, Alberta, March 26, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a […]
Draganfly Selected to Globally Integrate Breakthrough Health Diagnosis Technology Immediately onto Autonomous Camera’s and Specialized Drones to Combat Coronavirus (COVID-19) and Future Health Emergencies
Partnering with The University of South Australia developers of the technology in collaboration with the Australian Department of Defence – […]
Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19
TORONTO, March 25, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a life sciences company […]
Primo Nutraceuticals Inc. Provides Updates on Company via YouTube Channel
VANCOUVER, British Columbia, March 25, 2020 (GLOBE NEWSWIRE) — via OTC PR WIRE — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: […]
